Annual EBITDA:
-$42.56M-$19.56M(-84.99%)Summary
- As of today, CAPR annual EBITDA is -$42.56 million, with the most recent change of -$19.56 million (-84.99%) on December 31, 2024.
- During the last 3 years, CAPR annual EBITDA has fallen by -$21.87 million (-105.70%).
- CAPR annual EBITDA is now -1531.04% below its all-time high of $2.97 million, reached on December 31, 2017.
Performance
CAPR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$25.79M+$1.44M(+5.30%)Summary
- As of today, CAPR quarterly EBITDA is -$25.79 million, with the most recent change of +$1.44 million (+5.30%) on September 30, 2025.
- Over the past year, CAPR quarterly EBITDA has dropped by -$13.14 million (-103.89%).
- CAPR quarterly EBITDA is now -260597.98% below its all-time high of $9900.00, reached on December 31, 2002.
Performance
CAPR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$84.92M-$13.14M(-18.31%)Summary
- As of today, CAPR TTM EBITDA is -$84.92 million, with the most recent change of -$13.14 million (-18.31%) on September 30, 2025.
- Over the past year, CAPR TTM EBITDA has dropped by -$50.35 million (-145.63%).
- CAPR TTM EBITDA is now -9435644.44% below its all-time high of -$900.00, reached on September 30, 2003.
Performance
CAPR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CAPR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -85.0% | -103.9% | -145.6% |
| 3Y3 Years | -105.7% | -308.2% | -209.8% |
| 5Y5 Years | -462.9% | -565.0% | -682.8% |
CAPR EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -105.7% | at low | -3314.0% | +5.3% | -272.4% | at low |
| 5Y | 5-Year | -462.9% | at low | -3314.0% | +5.3% | -682.8% | at low |
| All-Time | All-Time | -1531.0% | at low | >-9999.0% | +5.3% | >-9999.0% | at low |
CAPR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$25.79M(+5.3%) | -$84.92M(-18.3%) |
| Jun 2025 | - | -$27.23M(-10.8%) | -$71.78M(-28.7%) |
| Mar 2025 | - | -$24.58M(-235.7%) | -$55.78M(-35.6%) |
| Dec 2024 | -$42.56M(-85.0%) | -$7.32M(+42.1%) | -$41.14M(-19.0%) |
| Sep 2024 | - | -$12.65M(-12.6%) | -$34.57M(-21.3%) |
| Jun 2024 | - | -$11.23M(-13.1%) | -$28.51M(-15.1%) |
| Mar 2024 | - | -$9.93M(-1215.1%) | -$24.78M(-8.7%) |
| Dec 2023 | -$23.01M(+21.1%) | -$755.40K(+88.5%) | -$22.80M(+23.8%) |
| Sep 2023 | - | -$6.59M(+12.1%) | -$29.93M(-0.9%) |
| Jun 2023 | - | -$7.50M(+5.8%) | -$29.66M(-1.0%) |
| Mar 2023 | - | -$7.96M(-1.0%) | -$29.37M(-1.3%) |
| Dec 2022 | -$29.16M(-40.9%) | -$7.88M(-24.7%) | -$28.99M(-5.8%) |
| Sep 2022 | - | -$6.32M(+12.4%) | -$27.41M(-8.2%) |
| Jun 2022 | - | -$7.21M(+4.9%) | -$25.34M(-9.4%) |
| Mar 2022 | - | -$7.58M(-20.3%) | -$23.16M(-11.9%) |
| Dec 2021 | -$20.69M(-52.8%) | -$6.30M(-48.3%) | -$20.69M(-11.7%) |
| Sep 2021 | - | -$4.25M(+15.5%) | -$18.53M(-2.0%) |
| Jun 2021 | - | -$5.03M(+1.6%) | -$18.16M(-9.5%) |
| Mar 2021 | - | -$5.11M(-23.5%) | -$16.58M(-22.4%) |
| Dec 2020 | -$13.55M(-79.1%) | -$4.14M(-6.7%) | -$13.55M(-24.9%) |
| Sep 2020 | - | -$3.88M(-12.2%) | -$10.85M(-26.8%) |
| Jun 2020 | - | -$3.46M(-66.6%) | -$8.56M(-20.1%) |
| Mar 2020 | - | -$2.07M(-44.0%) | -$7.12M(+7.1%) |
| Dec 2019 | -$7.56M(+50.2%) | -$1.44M(+9.1%) | -$7.67M(+19.3%) |
| Sep 2019 | - | -$1.58M(+21.6%) | -$9.50M(+21.2%) |
| Jun 2019 | - | -$2.02M(+22.8%) | -$12.05M(+14.9%) |
| Mar 2019 | - | -$2.62M(+19.8%) | -$14.16M(+6.8%) |
| Dec 2018 | -$15.17M(-610.0%) | -$3.27M(+21.0%) | -$15.20M(-0.1%) |
| Sep 2018 | - | -$4.14M(-0.2%) | -$15.18M(-11.2%) |
| Jun 2018 | - | -$4.13M(-12.9%) | -$13.66M(-6.1%) |
| Mar 2018 | - | -$3.66M(-12.5%) | -$12.87M(-1.0%) |
| Dec 2017 | $2.97M(+116.2%) | -$3.25M(-24.6%) | -$12.75M(-1.2%) |
| Sep 2017 | - | -$2.61M(+22.0%) | -$12.60M(+17.5%) |
| Jun 2017 | - | -$3.35M(+5.2%) | -$15.26M(+8.7%) |
| Mar 2017 | - | -$3.53M(-13.9%) | -$16.72M(+5.4%) |
| Dec 2016 | -$18.34M(-46.7%) | -$3.10M(+41.2%) | -$17.67M(+2.1%) |
| Sep 2016 | - | -$5.28M(-9.8%) | -$18.04M(-12.8%) |
| Jun 2016 | - | -$4.80M(-7.0%) | -$16.00M(-9.5%) |
| Mar 2016 | - | -$4.49M(-29.3%) | -$14.62M(-8.1%) |
| Dec 2015 | -$12.50M(-109.2%) | -$3.47M(-7.4%) | -$13.52M(-10.2%) |
| Sep 2015 | - | -$3.23M(+5.6%) | -$12.27M(-13.9%) |
| Jun 2015 | - | -$3.42M(-1.0%) | -$10.77M(-22.0%) |
| Mar 2015 | - | -$3.39M(-52.7%) | -$8.83M(-33.4%) |
| Dec 2014 | -$5.97M(+32.2%) | -$2.22M(-27.6%) | -$6.62M(+38.4%) |
| Sep 2014 | - | -$1.74M(-17.7%) | -$10.74M(-15.6%) |
| Jun 2014 | - | -$1.48M(-25.4%) | -$9.29M(-12.8%) |
| Mar 2014 | - | -$1.18M(+81.4%) | -$8.23M(-11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$8.81M(-329.4%) | -$6.34M(-2073.5%) | -$7.38M(-444.6%) |
| Sep 2013 | - | -$291.80K(+30.7%) | -$1.35M(+17.3%) |
| Jun 2013 | - | -$421.00K(-29.9%) | -$1.64M(+17.7%) |
| Mar 2013 | - | -$324.10K(-1.9%) | -$1.99M(+18.2%) |
| Dec 2012 | -$2.05M(+58.0%) | -$318.10K(+44.7%) | -$2.43M(+38.8%) |
| Sep 2012 | - | -$574.90K(+25.6%) | -$3.97M(+25.9%) |
| Jun 2012 | - | -$772.90K(-0.6%) | -$5.37M(+7.8%) |
| Mar 2012 | - | -$768.10K(+58.7%) | -$5.82M(+6.8%) |
| Dec 2011 | -$4.88M(+22.3%) | -$1.86M(+5.5%) | -$6.25M(-14.8%) |
| Sep 2011 | - | -$1.97M(-60.7%) | -$5.44M(-3.0%) |
| Jun 2011 | - | -$1.22M(-2.4%) | -$5.29M(+4.9%) |
| Mar 2011 | - | -$1.20M(-13.3%) | -$5.56M(+10.2%) |
| Dec 2010 | -$6.28M(+18.7%) | -$1.06M(+41.7%) | -$6.19M(+8.0%) |
| Sep 2010 | - | -$1.81M(-20.8%) | -$6.73M(+2.6%) |
| Jun 2010 | - | -$1.50M(+18.0%) | -$6.91M(+12.4%) |
| Mar 2010 | - | -$1.83M(-14.4%) | -$7.89M(-2.1%) |
| Dec 2009 | -$7.72M(+41.9%) | -$1.60M(+19.9%) | -$7.72M(+15.1%) |
| Sep 2009 | - | -$1.99M(+19.5%) | -$9.10M(+13.0%) |
| Jun 2009 | - | -$2.47M(-48.8%) | -$10.45M(+11.4%) |
| Mar 2009 | - | -$1.66M(+44.0%) | -$11.80M(+11.2%) |
| Dec 2008 | -$13.29M(-40.3%) | -$2.97M(+11.2%) | -$13.29M(-2.0%) |
| Sep 2008 | - | -$3.35M(+12.4%) | -$13.02M(+9.0%) |
| Jun 2008 | - | -$3.82M(-21.2%) | -$14.31M(-36.4%) |
| Mar 2008 | - | -$3.15M(-16.6%) | -$10.49M(-43.0%) |
| Dec 2007 | -$9.47M(-279.2%) | -$2.70M(+41.6%) | -$7.34M(-58.4%) |
| Sep 2007 | - | -$4.63M(>-9900.0%) | -$4.63M(>-9900.0%) |
| Dec 2006 | -$2.50M(>-9900.0%) | - | - |
| Mar 2006 | - | -$7200.00(-111.8%) | -$13.60K(-15.3%) |
| Dec 2005 | -$18.90K(+0.5%) | - | - |
| Sep 2005 | - | -$3400.00(-13.3%) | -$11.80K(-40.5%) |
| Jun 2005 | - | -$3000.00(+44.4%) | -$8400.00(-55.6%) |
| Mar 2005 | - | -$5400.00(0.0%) | -$5400.00(+66.7%) |
| Dec 2004 | -$19.00K(-17.3%) | - | - |
| Dec 2003 | -$16.20K(+9.0%) | -$5400.00(-5300.0%) | -$16.20K(-1700.0%) |
| Sep 2003 | - | -$100.00(+98.6%) | -$900.00(+90.4%) |
| Jun 2003 | - | -$7000.00(-89.2%) | -$9400.00(+42.0%) |
| Mar 2003 | - | -$3700.00(-137.4%) | -$16.20K(+13.4%) |
| Dec 2002 | -$17.80K(+19.8%) | $9900.00(+215.1%) | -$18.70K(+40.4%) |
| Sep 2002 | - | -$8600.00(+37.7%) | -$31.40K(-14.2%) |
| Jun 2002 | - | -$13.80K(-122.6%) | -$27.50K(0.0%) |
| Mar 2002 | - | -$6200.00(-121.4%) | -$27.50K(+9.5%) |
| Dec 2001 | -$22.20K(+38.8%) | -$2800.00(+40.4%) | -$30.40K(-10.1%) |
| Sep 2001 | - | -$4700.00(+65.9%) | -$27.60K(-20.5%) |
| Jun 2001 | - | -$13.80K(-51.6%) | -$22.90K(-151.6%) |
| Mar 2001 | - | -$9100.00 | -$9100.00 |
| Dec 2000 | -$36.30K(>-9900.0%) | - | - |
| Dec 1999 | $0.00 | - | - |
FAQ
- What is Capricor Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Capricor Therapeutics, Inc.?
- What is Capricor Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Capricor Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Capricor Therapeutics, Inc.?
- What is Capricor Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Capricor Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Capricor Therapeutics, Inc.?
- What is Capricor Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Capricor Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of CAPR is -$42.56M
What is the all-time high annual EBITDA for Capricor Therapeutics, Inc.?
Capricor Therapeutics, Inc. all-time high annual EBITDA is $2.97M
What is Capricor Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, CAPR annual EBITDA has changed by -$19.56M (-84.99%)
What is Capricor Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of CAPR is -$25.79M
What is the all-time high quarterly EBITDA for Capricor Therapeutics, Inc.?
Capricor Therapeutics, Inc. all-time high quarterly EBITDA is $9900.00
What is Capricor Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, CAPR quarterly EBITDA has changed by -$13.14M (-103.89%)
What is Capricor Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of CAPR is -$84.92M
What is the all-time high TTM EBITDA for Capricor Therapeutics, Inc.?
Capricor Therapeutics, Inc. all-time high TTM EBITDA is -$900.00
What is Capricor Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, CAPR TTM EBITDA has changed by -$50.35M (-145.63%)